Haleon (HLN) "Could be a Mini Kenvue," Says Jim Cramer

We recently published Jim Cramer Discussed These 25 Stocks In An Important Show About AI Spending. Haleon plc (NYSE:HLN) is one of the stocks Jim Cramer recently discussed.

Haleon plc (NYSE:HLN) is a consumer products company that sells items such as toothpaste and pain relief products. The firm owns several well-known brands such as Sensodyne and Panadol. Cramer recently discussed the firm and pointed out that while it appeared to be struggling in North America, it was experiencing strong growth in regions such as Latin America and India. Haleon plc (NYSE:HLN) reported its third-quarter earnings in late October and posted a 0.4% growth in its US same-store sales that was starkly different from the 1.4% dip that analysts had forecast. Haleon plc (NYSE:HLN)’s US sales results pointed towards a tight consumer economy, as while revenue from its defensive product line, Sensodyne, grew, sales of discretionary brands dropped. Cramer remarked that Haleon plc (NYSE:HLN) could be another Kenvue without the controversies surrounding Tylenol:

“I’ve got Haleon, which to me is kind of mini, you know Kenvue, could be a mini Kenvue, without the kind of the sticking points of Kenvue, you know like Tylenol. And then, [inaudible] going to introduce a new product into it.”

While we acknowledge the potential of HLN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.